Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hasan Yalim Akin"'
Autor:
Emine Begum Gencer-Oncul, Guldane Cengiz Seval, Ezgi Gülten, Hasan Yalim Akin, Meral Beksac, Mahsa Yousefzadeh, Güle Çınar, Osman Memikoglu, İrem Akdemir Kalkan, Klara Dalva, Ergun Karaagaoglu
Publikováno v:
Immunogenetics
Graphical abstract Associations between inherited Killer Immunoglobulin-like Receptor (KIR) genotypes and the severity of multiple RNA virus infections have been reported. This prospective study was initiated to investigate if such an association exi
Autor:
Emine Begum Gencer-Oncul, Eylul Turasan, Hasan Yalim Akin, Pinar Yurdakul-Mesutoglu, Mehmet Murat Seval, Murat Cagan, Acar Koc, Mehmet Sinan Beksac, Klara Dalva, Meral Beksac
Publikováno v:
Transplantation and Cellular Therapy. 28:S337-S339
Autor:
Meral Beksac, Hasan Yalim Akin, Guldane Cengiz Seval, Pinar Yurdakul Mesutoglu, Rıdvan Goksel Anliacik, Ezgi Anliacik, Gunhan Gurman, Ergun Karaagaoglu, Klara Dalva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:394-400.e1
Autor:
Guidane Cengiz Seval, Pinar Ataca Atilla, Klara Dalva, Taner Otlu, Meral Beksac, Hasan Yalim Akin, Gunhan Gurman, Ridvan Anliacik, Pinar Yurdakul Mesutoglu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S76
Background Natural killer (NK) cells are known for their anti-tumoral cytotoxic effects. Effector NK-cell functions are controlled by interactions between inhibitory and activating killer-cell immnuglobulin-like receptors (iKIRs and aKIRs) on NK cell
Autor:
Guldane Cengiz Seval, Meral Beksac, Klara Dalva, Hasan Yalim Akin, Pinar Yurdakul-Mesutoglu, Eylul Turasan, Ekin Kircali, Erman Akkus
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S315
Instruction Killer Immunoglobulin-like Receptor (KIR) inhibition is known to influence the cytotoxic effects of natural killer (NK) cells against cancer cells. KIRs can be protective against relapse in myeloma (MM) (Gabriel et al Blood 2010, Kroger e
Autor:
P. Yurdakul-Mesutoglu, E. Fadiloglu, Mehmet Sinan Beksac, H. Karakaya, A. Tanacan, Hasan Yalim Akin, Y. Dilek, M. S. Ozisik, E. Turasan
Publikováno v:
HemaSphere. 3:1060-1061
Autor:
Mustafa Merter, Merve Bunsuz, Klara Dalva, Cemalettin Ozturk, Eylul Turasan, Meral Beksac, Hasan Yalim Akin, Pinar Yurdakul Mesutoglu
Publikováno v:
Blood. 132:1920-1920
Background and Aim: NK cell effects are mediated by Killer Immunoglobulin-like Receptor (KIR) inhibition. There are few reports on the protective role of KIRs against relapse in myeloma(MM) (Gabriel et al Blood 2010, Kröger et al leukemia 2011). How
Autor:
M. Bunsuz Sengun, G. Aydin, Klara Dalva, Hasan Yalim Akin, Eylul Turasan, Pinar Yurdakul, Meral Beksac
Publikováno v:
Cytotherapy. 20:e9
Publikováno v:
Cytotherapy. 19:S83
Autor:
Emine Begüm Gençer, Meral Beksac, Sinan Beksaç, Klara Dalva, Hasan Yalim Akin, Pinar Yurdakul, D. Katlan
Publikováno v:
Cytotherapy. 18:S42